Stephanie Nardoza
About Stephanie Nardoza
Stephanie Nardoza is the Early Clinical Development Protocol Review Committee Process Lead at Bristol Myers Squibb in Princeton, New Jersey.
Title
Stephanie Nardoza is the Early Clinical Development Protocol Review Committee Process Lead at Bristol Myers Squibb. She is based in Princeton, New Jersey, United States.
Current Role at Bristol Myers Squibb
Stephanie Nardoza currently serves as the Early Clinical Development Protocol Review Committee Process Lead at Bristol Myers Squibb. Since October 2020, she has been directing the process of early clinical development protocol reviews at the company's Princeton, New Jersey location.
Career at Bristol Myers Squibb
Stephanie initially joined Bristol Myers Squibb as the Early Clinical Development Protocol Review Committee Coordinator in 2020. Her tenure in this position lasted for one month, after which she ascended to her current role as Process Lead. In this capacity, she oversees the systematic review of early clinical development protocols, ensuring smooth and thorough evaluations.
Previous Role at Coty
Before her current tenure at Bristol Myers Squibb, Stephanie Nardoza worked at Coty in Morris Plains R&D as the Manager of Site Administration. From 2019 to 2020, she handled administrative functions essential to the site’s research and development operations, assisting in workflow management and operational oversight.
Education and Expertise
Stephanie Nardoza is an alumna of Monmouth University. Her educational background has equipped her with the knowledge and skills necessary for her roles in clinical development and site administration, contributing to her professional expertise in these domains.